ArticleMedComm2026

A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells.

Jae Hyeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.